AA
CRL icon

Axiom Advisory’s Charles River Laboratories CRL Stock Holding History

Axiom Advisory’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$359K Buy
1,728
+27
+2% +$5.61K ﹤0.01% 244
2024
Q2 		$385K Buy
+1,701
New +$385K ﹤0.01% 231

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Axiom Advisory's CRL Position: Q3 2024 in Review

Axiom Advisory increased its Charles River Laboratories (CRL) stake by 1.6% in Q3 2024, buying an estimated $5.61K and bringing the position to 1,728 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #244.

Axiom Advisory first reported a position in CRL in Q2 2024 and has held it in 2 quarters since. The position peaked at $385K in Q2 2024. 627 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • Axiom Advisory held 1,728 shares of Charles River Laboratories worth $359K as of Q3 2024.
  • Axiom Advisory bought 27 Charles River Laboratories shares in Q3 2024, an estimated $5.61K.
  • Charles River Laboratories made up ﹤0.01% of Axiom Advisory's portfolio in Q3 2024, its #244 holding.
  • Axiom Advisory first reported a position in Charles River Laboratories in Q2 2024 and has held it in 2 quarters since.
  • Axiom Advisory's Charles River Laboratories position peaked at $385K in Q2 2024.
  • 627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on Axiom Advisory's 13F filing for Q3 2024, filed 7 Oct 2024.